Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Nuvalent, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 70 shares of NUVL stock, worth $6,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$6,741
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
210Shares Held
59.5MCall Options Held
450KPut Options Held
619K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.93 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$482 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$291 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$287 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.14B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...